Advancing treatments for chronic dermatological conditions
Henlez has raised €1.0M across 1 funding round from 2 investors, most recently a Seed round in Oct 2022. Based in Denmark; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-27 | Seed | €1.0M |
| EIR Ventures,Karolinska Development |
| View deal → |
